Eris Lifesciences Ltd - 540596 - Corporate Presentation
Pursuant to the requirement of regulation 30 of SEBI (LODR), regulations 2015, please find the attached corporate presentation made by the company.17-08-2023
17-08-2023
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Analyst and Investor Call11-08-2023
Buy Eris Lifesciences; target of Rs 910: Prabhudas Lilladher
Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 910 in its research report dated August 08, 2023.10-08-2023
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING10-08-2023
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
In accordance with the applicable requirements and regulations of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and other applicable Regulations, we hereby inform you that the Audio Recording of the Earnings Conference Call in connection with the Unaudited Consolidated and Standalone Financial Results of the Company for the quarter ended 30th June 2023, held on Monday, 07 August 2023, is available on the website of the Company and can be accessed through the following link: Link: https://eris.co.in/financials/ (File name: Q1 FY24-Earnings Call Recording)07-08-2023
Eris Lifesciences Results Earnings Call for Q1FY24
Conference Call with Eris Lifesciences Management and Analysts on Q1FY24 Performance and Outlook. Listen to the full earnings transcript.07-08-2023
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation07-08-2023
Eris Lifesciences Ltd - 540596 - OUTCOME OF THE BOARD MEETING HELD TODAY, I.E., AUGUST 07, 2023
Outcome of the Board Meeting held today, i.e., August 07, 202307-08-2023
Eris Lifesciences Ltd - 540596 - Board Meeting Outcome for OUTCOME OF THE BOARD MEETING HELD TODAY, I.E., AUGUST 07, 2023
Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company, in their meeting held today, i.e., August 07, 2023, inter alia, duly approved/took on record the following: ? The limited reviewed unaudited Standalone & Consolidated Financial Results for the quarter ended June 30, 2023; ? Convening of 17th Annual General Meeting of the Members of the Company on Monday, September 25, 2023. Please find enclosed limited reviewed standalone and consolidated unaudited financial results for the quarter ended June 30, 2023 The meeting of the Board of Directors commenced at 11:00 A.M. and concluded at 12:50 P.M. This is for your information and record.07-08-2023
Eris Lifesciences aims to tap the underpenetrated Indian women's health market
Firm's COO Krishnakumar V says the market for such treatments, particularly IVF hormones, is predicted to grow 1617% per annum until the end of the decade01-08-2023